A detailed history of Hillsdale Investment Management Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Hillsdale Investment Management Inc. holds 6,050 shares of BSX stock, worth $609,356. This represents 0.03% of its overall portfolio holdings.

Number of Shares
6,050
Previous 8,500 28.82%
Holding current value
$609,356
Previous $759,000 19.63%
% of portfolio
0.03%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025

SELL
$89.38 - $106.18 $218,981 - $260,141
-2,450 Reduced 28.82%
6,050 $610,000
Q4 2024

Feb 11, 2025

BUY
$83.62 - $91.5 $710,770 - $777,750
8,500 New
8,500 $759,000
Q3 2023

Nov 09, 2023

BUY
$50.19 - $54.68 $85,323 - $92,956
1,700 Added 19.54%
10,400 $549,000
Q2 2023

Aug 11, 2023

BUY
$49.72 - $54.64 $432,564 - $475,368
8,700 New
8,700 $470,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $144B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Hillsdale Investment Management Inc. Portfolio

Follow Hillsdale Investment Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hillsdale Investment Management Inc. with notifications on news.